Ecopetrol
EC
Coinbase
COIN
MicroStrategy
MSTR
Petroleo Brasileiro SA Petrobras
PBR
MARA Holdings
MARA
US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.440
- +0.021+5.09%
Close Jan 2 16:00 ET
18.37MMarket Cap-0.29P/E (TTM)
0.480High0.400Low253.55KVolume0.400Open0.419Pre Close112.93KTurnover0.84%Turnover RatioLossP/E (Static)41.75MShares2.94052wk High-1.65P/B13.30MFloat Cap0.38052wk Low--Dividend TTM30.22MShs Float51.357Historical High--Div YieldTTM19.08%Amplitude0.380Historical Low0.445Avg Price1Lot Size
Carisma Therapeutics News
H.C. Wainwright Downgrades Carisma Therapeutics(CARM.US) to Hold Rating
CARISMA Therapeutics Analyst Ratings
Carisma Therapeutics Price Target Cut to $1.00/Share From $10.00 by Baird
Baird Downgrades Carisma Therapeutics(CARM.US) to Hold Rating, Cuts Target Price to $1
BTIG Maintains Carisma Therapeutics(CARM.US) With Hold Rating
Carisma Therapeutics: Hold Rating Amid Strategic Shift and Uncertain Pipeline Prospects
Carisma Therapeutics Cut to In-Line From Outperform by Evercore ISI Group
Carisma Therapeutics Price Target Cut to $0.70/Share From $4.00 by Evercore ISI Group
Evercore Downgrades Carisma Therapeutics(CARM.US) to Hold Rating, Cuts Target Price to $0.7
Carisma Therapeutics Cut to Neutral From Buy by BTIG
BTIG Downgrades Carisma Therapeutics(CARM.US) to Hold Rating
BTIG Downgrades Carisma Therapeutics (CARM) to a Hold
CARISMA Therapeutics Analyst Ratings
Carisma Therapeutics Is Maintained at Buy by D. Boral Capital
Carisma Therapeutics Price Target Maintained With a $24.00/Share by D. Boral Capital
Optimistic Buy Rating for Carisma Therapeutics Amid Promising CAR-Myeloid Developments and Strong Financial Standing
Evercore Maintains Carisma Therapeutics(CARM.US) With Buy Rating, Maintains Target Price $4
Evercore ISI Remains a Buy on Carisma Therapeutics (CARM)
CARISMA Therapeutics Analyst Ratings
EF Hutton Initiates Coverage On CARISMA Therapeutics With Buy Rating, Announces Price Target of $24
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.